These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

44 related articles for article (PubMed ID: 2558600)

  • 1. [Apropos of the monitoring of treatment with low molecular weight heparins].
    Toulemonde F; Bayrou B
    Ann Biol Clin (Paris); 1989; 47(9):561-2. PubMed ID: 2558600
    [No Abstract]   [Full Text] [Related]  

  • 2. Low-molecular-weight heparin in the treatment of pulmonary embolism.
    Ageno W; Turpie AG
    Semin Vasc Surg; 2000 Sep; 13(3):189-93. PubMed ID: 11005462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Are all low molecular weight heparins equivalent in the management of venous thromboembolism?
    Fareed J; Jeske W; Fareed D; Clark M; Wahi R; Adiguzel C; Hoppensteadt D
    Clin Appl Thromb Hemost; 2008 Oct; 14(4):385-92. PubMed ID: 18815137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low molecular weight heparins--state-of-the-art and unsolved issues.
    Breddin HK
    Blood Coagul Fibrinolysis; 1993 Dec; 4 Suppl 1():S17-9. PubMed ID: 8180324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The activity of unfractionated heparin and low molecular weight heparins in rabbit plasma--the need for using absolute anti-factor Xa and antithrombin activities.
    Peyrou V; Béguin S; Boneu B; Hemker HC
    Thromb Haemost; 1997 Feb; 77(2):312-6. PubMed ID: 9157588
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of venous thromboembolism: unfractionated heparin or low molecular weight heparins?
    Agnelli G
    Haematologica; 1995; 80(2 Suppl):78-83. PubMed ID: 7628776
    [No Abstract]   [Full Text] [Related]  

  • 7. Monitoring antifactor Xa activity of the low-molecular-weight heparins in the clinical setting: who, why, how, and when?
    Kalus JS; White CM
    Conn Med; 2002 Dec; 66(12):749-52. PubMed ID: 12532610
    [No Abstract]   [Full Text] [Related]  

  • 8. [Low molecular weight heparins: mechanisms of action and pharmococynetics. Clinical advantages over the classic unfractioned heparins].
    Campos M
    Rev Port Cir Cardiotorac Vasc; 2003; 10(2):61-7. PubMed ID: 15094887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. More on: is laboratory monitoring of low-molecular-weight heparin necessary?
    Shojania AM
    J Thromb Haemost; 2004 Dec; 2(12):2276-7. PubMed ID: 15613053
    [No Abstract]   [Full Text] [Related]  

  • 10. Is there enough evidence that low-molecular-weight heparin is superior to unfractionated heparin in pulmonary embolism?
    Sharma GK
    Arch Intern Med; 2000 Jul; 160(13):2065-6. PubMed ID: 10888989
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical and economic impact of low-molecular weight heparins in managed care. Introduction.
    Am J Manag Care; 2000 Nov; 6(20 Suppl):S1024-5. PubMed ID: 11484301
    [No Abstract]   [Full Text] [Related]  

  • 12. [Ambulatory treatment of pulmonary artery embolism with low molecular weight heparin].
    Stammler F
    Dtsch Med Wochenschr; 2000 Jun; 125(22):711-2. PubMed ID: 10874899
    [No Abstract]   [Full Text] [Related]  

  • 13. Heparin: from animal organ extract to designer drug.
    Middeldorp S
    Thromb Res; 2008; 122(6):753-62. PubMed ID: 17996279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [New medical anticoagulants].
    Choussat R; Montalescot G
    Rev Mal Respir; 1999 Nov; 16(5 Pt 2):985-95. PubMed ID: 10907447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Low molecular weight heparin in a patient with pulmonary embolism and heparin-induced thrombocytopenia].
    Monreal M; Torrabadella P; Roncales J; Torguet P
    Med Clin (Barc); 1988 Nov; 91(16):638-9. PubMed ID: 2852738
    [No Abstract]   [Full Text] [Related]  

  • 16. Low-molecular weight heparin for treatment of pulmonary embolism in a pregnant woman.
    Laifer SA; Stiller RJ; Dunston-Boone G; Whetham JC
    Thromb Haemost; 1999 Oct; 82(4):1361-2. PubMed ID: 10544931
    [No Abstract]   [Full Text] [Related]  

  • 17. Low molecular weight heparins: the optimal treatment for venous thromboembolism.
    Daskalopoulos ME; Daskalopoulou SS; Liapis CD
    Curr Med Res Opin; 2004 Jul; 20(7):1001-5. PubMed ID: 15265244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monitoring of heparins in haemodialysis using an anti-factor-Xa-specific whole-blood clotting assay.
    Harenberg J; Haaf B; Dempfle CE; Stehle G; Heene DL
    Nephrol Dial Transplant; 1995; 10(2):217-22. PubMed ID: 7753456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Low-molecular weight heparins in post-surgical recovery].
    Doutremepuich C; Anne MC; Fernandez G; Pereira F; de Seze O; Doutremepuich F
    Ann Biol Clin (Paris); 1988; 46(3):190-4. PubMed ID: 2841894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Therapy of thromboses with low-molecular-weight heparins].
    Haas S; Haas P
    Wien Med Wochenschr; 1999; 149(2-4):39-45; discussion 45. PubMed ID: 10378321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.